Resources

The results suggest that very early identification of dysglycemia may provide at-risk individuals with ample time to make long-lasting lifestyle changes that could prevent future diabetes….

Without a doubt, growth in the use of safety technologies will have a major impact on decreasing medical errors. For example, safety will improve with….  

Q: Dr. Sheri, I am a 41-year-old female and have been a long distance runner for most of my life. I am quite thin (bordering on underweight for many years) and already eat as a diabetic would to control blood glucose. Recently, I had my HbA1c checked with readings of 5.5 and then …

CeQur Insulin Pump Patch for Type 2’s   The CeQur insulin pump patch is a small, discreet and wearable insulin patch infuser for the continuous subcutaneous delivery of rapid acting insulin. The CeQur Device, which is not yet approved, features up to three days of consistent basal infusion (on-demand bolus …

In the first clinical trial of a system using two hormones, an artificial pancreas delivered insulin and glucagon in a way that closely mimics the body’s control of blood sugar and maintained near-normal levels of glucose in a small group of Type 1 diabetes patients without them developing hypoglycemia….

You’ve probably heard that eating smaller meals, several times a day will stimulate your metabolism, and keep it revved to burn more calories throughout your day. But a recent article in the New York Times points out that although some studies have found modest health benefits to eating smaller meals, the …

There may be a reason Colorado has one of the nation’s lowest rates of diabetes. Scientists who bred mice missing a gene — which regulates response to low oxygen levels — found they stay thin and healthy and avoid fatty livers and diabetes even when….

Translating A1c into eAG produced biased estimates of MBG downloaded from patient glucose meters….

Parents who live in fear of their children having hypoglycemic episodes might have a negative effect on their child’s diabetes control, says a new study. Good provision of psychological support for parents and their children with diabetes is therefore crucial….

Sanofi-aventis announced the positive results of the first, placebo-controlled study of the GetGoal Phase III clinical trial program with lixisenatide, a novel, once daily GLP-1 agonist, for the treatment of Type-2 diabetes (T2DM)….